ROS/oxidative stress signaling in osteoarthritis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1862, Issue 4, 2016, Pages 576-591

  Lepetsos, Panagiotis ^a   Papavassiliou, Athanasios G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Cartilage; Chondrocytes; NO; Osteoarthritis; Oxidative stress; Reactive oxygen species

Indexed keywords

ANTIOXIDANT; HERBACEOUS AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; POLYPHENOL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SCAVENGER;

APOPTOSIS; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL DESTRUCTION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXTRACELLULAR MATRIX; HERBAL MEDICINE; HUMAN; INTRACELLULAR SIGNALING; MOLECULAR PATHOLOGY; NONHUMAN; OSTEOARTHRITIS; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; SYNOVIUM;

EID: 84958279170     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2016.01.003     Document Type: Review

References (331)

1. Xia B., Di C., Zhang J., Hu S., Jin H., Tong P. Osteoarthritis pathogenesis: a review of molecular mechanisms. Calcif. Tissue Int. 2014, 95:495-505.
2. Li D., Xie G., Wang W. Reactive oxygen species: the 2-edged sword of osteoarthritis. Am. J. Med. Sci. 2012, 344:486-490.
3. Henrotin Y., Kurz B., Aigner T. Oxygen and reactive oxygen species in cartilage degradation: friends or foes?. Osteoarthr. Cartil. 2005, 13:643-654.
4. Adam-Vizi V., Chinopoulos C. Bioenergetics and the formation of mitochondrial reactive oxygen species. Trends Pharmacol. Sci. 2006, 27:639-645.
5. Turrens J.F. Mitochondrial formation of reactive oxygen species. J. Physiol. 2003, 552:335-344.
6. Chance B., Williams G.R. Respiratory enzymes in oxidative phosphorylation. I. Kinetics of oxygen utilization. J. Biolumin. Chemilumin. 1955, 217:383-393.
7. Lambeth J.D. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 2004, 4:181-189.
8. DeLeo F.R., Quinn M.T. Assembly of the phagocyte NADPH oxidase: molecular interaction of oxidase proteins. J. Leukoc. Biol. 1996, 60:677-691.
9. Babior B.M. NADPH oxidase. Curr. Opin. Immunol. 2004, 16:42-47.
10. Dawson J., Walters M. Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?. Br. J. Clin. Pharmacol. 2006, 62:633-644.
11. + homeostasis in articular chondrocytes. Pflugers Arch. 2009, 458:1085-1092.
12. Fattman C.L., Schaefer L.M., Oury T.D. Extracellular superoxide dismutase in biology and medicine. Free Radic. Biol. Med. 2003, 35:236-256.
13. Trachootham D., Lu W., Ogasawara M.A., Nilsa R.D., Huang P. Redox regulation of cell survival. Antioxid. Redox Signal. 2008, 10:1343-1374.
14. Betteridge D.J. What is oxidative stress?. Metabolism 2000, 49:3-8.
15. Jones D.P. Radical-free biology of oxidative stress. Am. J. Physiol. Cell Physiol. 2008, 295:C849-C868.
16. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992, 6:3051-3064.
17. Squadrito G.L., Pryor W.A. Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide. Free Radic. Biol. Med. 1998, 25:392-403.
18. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408:239-247.
19. Kamata H., Hirata H. Redox regulation of cellular signalling. Cell. Signal. 1999, 11:1-14.
20. Poole L.B., Karplus P.A., Claiborne A. Protein sulfenic acids in redox signaling. Annu. Rev. Pharmacol. Toxicol. 2004, 44:325-347.
21. Gopalakrishna R., Jaken S. Protein kinase C signaling and oxidative stress. Free Radic. Biol. Med. 2000, 28:1349-1361.
22. Meng T.C., Fukada T., Tonks N.K. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell 2002, 9:387-399.
23. Thannickal V.J., Fanburg B.L. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 279:L1005-L1028.
24. Rush J.D., Koppenol W.H. Oxidizing intermediates in the reaction of ferrous EDTA with hydrogen peroxide. Reactions with organic molecules and ferrocytochrome c. J. Biolumin. Chemilumin. 1986, 261:6730-6733.
25. Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am. J. Med. 1991, 91:14S-22S.
26. Lo Y.Y., Cruz T.F. Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J. Biolumin. Chemilumin. 1995, 270:11727-11730.
27. Mobasheri A., Matta C., Zakany R., Musumeci G. Chondrosenescence: definition, hallmarks and potential role in the pathogenesis of osteoarthritis. Maturitas 2015, 80:237-244.
28. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 2007, 87:245-313.
29. Francis S.H., Busch J.L., Corbin J.D., Sibley D. cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol. Rev. 2010, 62:525-563.
30. Hanafy K.A., Krumenacker J.S., Murad F. NO, nitrotyrosine, and cyclic GMP in signal transduction. Med. Sci. Monit. 2001, 7:801-819.
31. Torres J., Cooper C.E., Wilson M.T. A common mechanism for the interaction of nitric oxide with the oxidized binuclear centre and oxygen intermediates of cytochrome c oxidase. J. Biolumin. Chemilumin. 1998, 273:8756-8766.
32. Hess D.T., Matsumoto A., Kim S.O., Marshall H.E., Stamler J.S. Protein S-nitrosylation: purview and parameters. Nat. Rev. Mol. Cell Biol. 2005, 6:150-166.
33. Sun J., Steenbergen C., Murphy E. S-nitrosylation: NO-related redox signaling to protect against oxidative stress. Antioxid. Redox Signal. 2006, 8:1693-1705.
34. Stamler J.S., Lamas S., Fang F.C. Nitrosylation. The prototypic redox-based signaling mechanism. Cell 2001, 106:675-683.
35. Matsumoto H., Silverton S.F., Debolt K., Shapiro I.M. Superoxide dismutase and catalase activities in the growth cartilage: relationship between oxidoreductase activity and chondrocyte maturation. J. Bone Miner. Res. 1991, 6:569-574.
36. Sen C.K. Oxygen toxicity and antioxidants: state of the art. Indian J. Physiol. Pharmacol. 1995, 39:177-196.
37. Henrotin Y., Kurz B. Antioxidant to treat osteoarthritis: dream or reality?. Curr. Drug Targets 2007, 8:347-357.
38. Petersen S.V., Oury T.D., Ostergaard L., Valnickova Z., Wegrzyn J., Thogersen I.B., Jacobsen C., Bowler R.P., Fattman C.L., Crapo J.D., Enghild J.J. Extracellular superoxide dismutase (EC-SOD) binds to type i collagen and protects against oxidative fragmentation. J. Biolumin. Chemilumin. 2004, 279:13705-13710.
39. Henrotin Y., Deby-Dupont G., Deby C., De Bruyn M., Lamy M., Franchimont P. Production of active oxygen species by isolated human chondrocytes. Br. J. Rheumatol. 1993, 32:562-567.
40. Rathakrishnan C., Tiku K., Raghavan A., Tiku M.L. Release of oxygen radicals by articular chondrocytes: a study of luminol-dependent chemiluminescence and hydrogen peroxide secretion. J. Bone Miner. Res. 1992, 7:1139-1148.
41. Tiku M.L., Liesch J.B., Robertson F.M. Production of hydrogen peroxide by rabbit articular chondrocytes. Enhancement by cytokines. J. Immunol. 1990, 145:690-696.
42. Henrotin Y.E., Bruckner P., Pujol J.P. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthr. Cartil. 2003, 11:747-755.
43. Altay M.A., Erturk C., Bilge A., Yapti M., Levent A., Aksoy N. Evaluation of prolidase activity and oxidative status in patients with knee osteoarthritis: relationships with radiographic severity and clinical parameters. Rheumatol. Int. 2015.
44. Erturk C., Altay M.A., Selek S., Kocyigit A. Paraoxonase-1 activity and oxidative status in patients with knee osteoarthritis and their relationship with radiological and clinical parameters. Scand. J. Clin. Lab. Invest. 2012, 72:433-439.
45. Altindag O., Erel O., Aksoy N., Selek S., Celik H., Karaoglanoglu M. Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis. Rheumatol. Int. 2007, 27:339-344.
46. Davies C.M., Guilak F., Weinberg J.B., Fermor B. Reactive nitrogen and oxygen species in interleukin-1-mediated DNA damage associated with osteoarthritis. Osteoarthr. Cartil. 2008, 16:624-630.
47. Karan A., Karan M.A., Vural P., Erten N., Tascioglu C., Aksoy C., Canbaz M., Oncel A. Synovial fluid nitric oxide levels in patients with knee osteoarthritis. Clin. Rheumatol. 2003, 22:397-399.
48. Sakurai H., Kohsaka H., Liu M.F., Higashiyama H., Hirata Y., Kanno K., Saito I., Miyasaka N. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J. Clin. Invest. 1995, 96:2357-2363.
49. Ersoy Y., Ozerol E., Baysal O., Temel I., MacWalter R.S., Meral U., Altay Z.E. Serum nitrate and nitrite levels in patients with rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. Ann. Rheum. Dis. 2002, 61:76-78.
50. Nemirovskiy O.V., Radabaugh M.R., Aggarwal P., Funckes-Shippy C.L., Mnich S.J., Meyer D.M., Sunyer T., Rodney Mathews W., Misko T.P. Plasma 3-nitrotyrosine is a biomarker in animal models of arthritis: pharmacological dissection of iNOS' role in disease. Nitric Oxide 2009, 20:150-156.
51. Ostalowska A., Birkner E., Wiecha M., Kasperczyk S., Kasperczyk A., Kapolka D., Zon-Giebel A. Lipid peroxidation and antioxidant enzymes in synovial fluid of patients with primary and secondary osteoarthritis of the knee joint. Osteoarthr. Cartil. 2006, 14:139-145.
52. Carlo M.D., Loeser R.F. Increased oxidative stress with aging reduces chondrocyte survival: correlation with intracellular glutathione levels. Arthritis Rheum. 2003, 48:3419-3430.
53. Regan E.A., Bowler R.P., Crapo J.D. Joint fluid antioxidants are decreased in osteoarthritic joints compared to joints with macroscopically intact cartilage and subacute injury. Osteoarthr. Cartil. 2008, 16:515-521.
54. Fernandez-Moreno M., Soto-Hermida A., Pertega S., Oreiro N., Fernandez-Lopez C., Rego-Perez I., Blanco F.J. Mitochondrial DNA (mtDNA) haplogroups and serum levels of anti-oxidant enzymes in patients with osteoarthritis. BMC Musculoskelet. Disord. 2011, 12:264.
55. Soran N., Altindag O., Cakir H., Celik H., Demirkol A., Aksoy N. Assessment of paraoxonase activities in patients with knee osteoarthritis. Redox Rep. 2008, 13:194-198.
56. Hiran T.S., Moulton P.J., Hancock J.T. Detection of superoxide and NADPH oxidase in porcine articular chondrocytes. Free Radic. Biol. Med. 1997, 23:736-743.
57. Moulton P.J., Goldring M.B., Hancock J.T. NADPH oxidase of chondrocytes contains an isoform of the gp91phox subunit. Biochem. J. 1998, 329(Pt 3):449-451.
58. Grange L., Nguyen M.V., Lardy B., Derouazi M., Campion Y., Trocme C., Paclet M.H., Gaudin P., Morel F. NAD(P)H oxidase activity of Nox4 in chondrocytes is both inducible and involved in collagenase expression. Antioxid. Redox Signal. 2006, 8:1485-1496.
59. van Lent P.L., Nabbe K.C., Blom A.B., Sloetjes A., Holthuysen A.E., Kolls J., Van De Loo F.A., Holland S.M., Van Den Berg W.B. NADPH-oxidase-driven oxygen radical production determines chondrocyte death and partly regulates metalloproteinase-mediated cartilage matrix degradation during interferon-gamma-stimulated immune complex arthritis. Arthritis Res. Ther. 2005, 7:R885-R895.
60. Palmer R.M., Hickery M.S., Charles I.G., Moncada S., Bayliss M.T. Induction of nitric oxide synthase in human chondrocytes. Biochem. Biophys. Res. Commun. 1993, 193:398-405.
61. Pelletier J.P., Lascau-Coman V., Jovanovic D., Fernandes J.C., Manning P., Connor J.R., Currie M.G., Martel-Pelletier J. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors. J. Rheumatol. 1999, 26:2002-2014.
62. Berenbaum F. Signaling transduction: target in osteoarthritis. Curr. Opin. Rheumatol. 2004, 16:616-622.
63. Xie Q.W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biolumin. Chemilumin. 1994, 269:4705-4708.
64. Rigoglou S., Papavassiliou A.G. The NF-kappaB signalling pathway in osteoarthritis. Int. J. Biochem. Cell Biol. 2013, 45:2580-2584.
65. Kleinert H., Pautz A., Linker K., Schwarz P.M. Regulation of the expression of inducible nitric oxide synthase. Eur. J. Pharmacol. 2004, 500:255-266.
66. Martel-Pelletier J., Mineau F., Jovanovic D., Di Battista J.A., Pelletier J.P. Mitogen-activated protein kinase and nuclear factor kappaB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: possible role of transactivating factor mitogen-activated protein kinase-activated proten kinase (MAPKAPK). Arthritis Rheum. 1999, 42:2399-2409.
67. Attur M.G., Patel R.N., Abramson S.B., Amin A.R. Interleukin-17 up-regulation of nitric oxide production in human osteoarthritis cartilage. Arthritis Rheum. 1997, 40:1050-1053.
68. Mendes A.F., Caramona M.M., Carvalho A.P., Lopes M.C. Differential roles of hydrogen peroxide and superoxide in mediating IL-1-induced NF-kappa B activation and iNOS expression in bovine articular chondrocytes. J. Cell. Biochem. 2003, 88:783-793.
69. Amin A.R., Di Cesare P.E., Vyas P., Attur M., Tzeng E., Billiar T.R., Stuchin S.A., Abramson S.B. The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for up-regulated neuronal nitric oxide synthase. J. Exp. Med. 1995, 182:2097-2102.
70. van den Berg W.B., van de Loo F., Joosten L.A., Arntz O.J. Animal models of arthritis in NOS2-deficient mice. Osteoarthr. Cartil. 1999, 7:413-415.
71. Mendes A.F., Carvalho A.P., Caramona M.M., Lopes M.C. Role of nitric oxide in the activation of NF-kappaB, AP-1 and NOS II expression in articular chondrocytes. Inflamm. Res. 2002, 51:369-375.
72. Rosa S.C., Judas F., Lopes M.C., Mendes A.F. Nitric oxide synthase isoforms and NF-kappaB activity in normal and osteoarthritic human chondrocytes: regulation by inducible nitric oxide. Nitric Oxide 2008, 19:276-283.
73. Lee R.B., Urban J.P. Evidence for a negative Pasteur effect in articular cartilage. Biochem. J. 1997, 321(Pt 1):95-102.
74. Blake D.R., Merry P., Unsworth J., Kidd B.L., Outhwaite J.M., Ballard R., Morris C.J., Gray L., Lunec J. Hypoxic-reperfusion injury in the inflamed human joint. Lancet 1989, 1:289-293.
75. Koike M., Nojiri H., Ozawa Y., Watanabe K., Muramatsu Y., Kaneko H., Morikawa D., Kobayashi K., Saita Y., Sasho T., Shirasawa T., Yokote K., Kaneko K., Shimizu T. Mechanical overloading causes mitochondrial superoxide and SOD2 imbalance in chondrocytes resulting in cartilage degeneration. Sci. Rep. 2015, 5:11722.
76. Beecher B.R., Martin J.A., Pedersen D.R., Heiner A.D., Buckwalter J.A. Antioxidants block cyclic loading induced chondrocyte death. Iowa Orthop. J. 2007, 27:1-8.
77. Moulton P.J., Hiran T.S., Goldring M.B., Hancock J.T. Detection of protein and mRNA of various components of the NADPH oxidase complex in an immortalized human chondrocyte line. Br. J. Rheumatol. 1997, 36:522-529.
78. Mathy-Hartert M., Deby-Dupont G.P., Reginster J.Y., Ayache N., Pujol J.P., Henrotin Y.E. Regulation by reactive oxygen species of interleukin-1beta, nitric oxide and prostaglandin E(2) production by human chondrocytes. Osteoarthr. Cartil. 2002, 10:547-555.
79. Fermor B., Christensen S.E., Youn I., Cernanec J.M., Davies C.M., Weinberg J.B. Oxygen, nitric oxide and articular cartilage. Eur. Cell. Mater. 2007, 13:56-65. discussion 65.
80. Radi R. Peroxynitrite reactions and diffusion in biology. Chem. Res. Toxicol. 1998, 11:720-721.
81. Yin W., Park J.I., Loeser R.F. Oxidative stress inhibits insulin-like growth factor-I induction of chondrocyte proteoglycan synthesis through differential regulation of phosphatidylinositol 3-kinase-Akt and MEK-ERK MAPK signaling pathways. J. Biolumin. Chemilumin. 2009, 284:31972-31981.
82. Yu S.M., Kim S.J. The thymoquinone-induced production of reactive oxygen species promotes dedifferentiation through the ERK pathway and inflammation through the p38 and PI3K pathways in rabbit articular chondrocytes. Int. J. Mol. Med. 2015, 35:325-332.
83. Lo Y.Y., Wong J.M., Cruz T.F. Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases. J. Biolumin. Chemilumin. 1996, 271:15703-15707.
84. Lo Y.Y., Conquer J.A., Grinstein S., Cruz T.F. Interleukin-1 beta induction of c-fos and collagenase expression in articular chondrocytes: involvement of reactive oxygen species. J. Cell. Biochem. 1998, 69:19-29.
85. Pelletier J.P., Mineau F., Ranger P., Tardif G., Martel-Pelletier J. The increased synthesis of inducible nitric oxide inhibits IL-1ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation. Osteoarthr. Cartil. 1996, 4:77-84.
86. Amin A.R., Attur M., Patel R.N., Thakker G.D., Marshall P.J., Rediske J., Stuchin S.A., Patel I.R., Abramson S.B. Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide. J. Clin. Invest. 1997, 99:1231-1237.
87. Boileau C., Martel-Pelletier J., Moldovan F., Jouzeau J.Y., Netter P., Manning P.T., Pelletier J.P. The in situ up-regulation of chondrocyte interleukin-1-converting enzyme and interleukin-18 levels in experimental osteoarthritis is mediated by nitric oxide. Arthritis Rheum. 2002, 46:2637-2647.
88. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:7240-7244.
89. Landino L.M., Crews B.C., Timmons M.D., Morrow J.D., Marnett L.J. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:15069-15074.
90. Whiteman M., Spencer J.P., Zhu Y.Z., Armstrong J.S., Schantz J.T. Peroxynitrite-modified collagen-II induces p38/ERK and NF-kappaB-dependent synthesis of prostaglandin E2 and nitric oxide in chondrogenically differentiated mesenchymal progenitor cells. Osteoarthr. Cartil. 2006, 14:460-470.
91. Henrotin Y.E., Zheng S.X., Deby G.P., Labasse A.H., Crielaard J.M., Reginster J.Y. Nitric oxide downregulates interleukin 1beta (IL-1beta) stimulated IL-6, IL-8, and prostaglandin E2 production by human chondrocytes. J. Rheumatol. 1998, 25:1595-1601.
92. Clancy R.M., Leszczynska-Piziak J., Abramson S.B. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J. Clin. Invest. 1992, 90:1116-1121.
93. Ginn-Pease M.E., Whisler R.L. Redox signals and NF-kappaB activation in T cells. Free Radic. Biol. Med. 1998, 25:346-361.
94. Blanco F.J., Guitian R., Vazquez-Martul E., de Toro F.J., Galdo F. Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology. Arthritis Rheum. 1998, 41:284-289.
95. Aigner T., Kim H.A. Apoptosis and cellular vitality: issues in osteoarthritic cartilage degeneration. Arthritis Rheum. 2002, 46:1986-1996.
96. Blanco F.J., Ochs R.L., Schwarz H., Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am. J. Pathol. 1995, 146:75-85.
97. Hashimoto S., Takahashi K., Amiel D., Coutts R.D., Lotz M. Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arthritis Rheum. 1998, 41:1266-1274.
98. Khan I.M., Gilbert S.J., Caterson B., Sandell L.J., Archer C.W. Oxidative stress induces expression of osteoarthritis markers procollagen IIA and 3B3(-) in adult bovine articular cartilage. Osteoarthr. Cartil. 2008, 16:698-707.
99. Yu S.M., Kim S.J. Withaferin A-caused production of intracellular reactive oxygen species modulates apoptosis via PI3K/Akt and JNKinase in rabbit articular chondrocytes. J. Korean Med. Sci. 2014, 29:1042-1053.
100. Vincent F., Brun H., Clain E., Ronot X., Adolphe M. Effects of oxygen-free radicals on proliferation kinetics of cultured rabbit articular chondrocytes. J. Cell. Physiol. 1989, 141:262-266.
101. Vaillancourt F., Fahmi H., Shi Q., Lavigne P., Ranger P., Fernandes J.C., Benderdour M. 4-Hydroxynonenal induces apoptosis in human osteoarthritic chondrocytes: the protective role of glutathione-S-transferase. Arthritis Res. Ther. 2008, 10:R107.
102. Notoya K., Jovanovic D.V., Reboul P., Martel-Pelletier J., Mineau F., Pelletier J.P. The induction of cell death in human osteoarthritis chondrocytes by nitric oxide is related to the production of prostaglandin E2 via the induction of cyclooxygenase-2. J. Immunol. 2000, 165:3402-3410.
103. Maneiro E., Lopez-Armada M.J., de Andres M.C., Carames B., Martin M.A., Bonilla A., Del Hoyo P., Galdo F., Arenas J., Blanco F.J. Effect of nitric oxide on mitochondrial respiratory activity of human articular chondrocytes. Ann. Rheum. Dis. 2005, 64:388-395.
104. Pelletier J.P., Fernandes J.C., Jovanovic D.V., Reboul P., Martel-Pelletier J. Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthase. J. Rheumatol. 2001, 28:2509-2519.
105. Del Carlo M., Loeser R.F. Nitric oxide-mediated chondrocyte cell death requires the generation of additional reactive oxygen species. Arthritis Rheum. 2002, 46:394-403.
106. Whiteman M., Armstrong J.S., Cheung N.S., Siau J.L., Rose P., Schantz J.T., Jones D.P., Halliwell B. Peroxynitrite mediates calcium-dependent mitochondrial dysfunction and cell death via activation of calpains. FASEB J. 2004, 18:1395-1397.
107. Studer R.K., Levicoff E., Georgescu H., Miller L., Jaffurs D., Evans C.H. Nitric oxide inhibits chondrocyte response to IGF-I: inhibition of IGF-IRbeta tyrosine phosphorylation. Am. J. Physiol. Cell Physiol. 2000, 279:C961-C969.
108. de Andres M.C., Maneiro E., Martin M.A., Arenas J., Blanco F.J. Nitric oxide compounds have different effects profiles on human articular chondrocyte metabolism. Arthritis Res. Ther. 2013, 15:R115.
109. Wu G.J., Chen T.G., Chang H.C., Chiu W.T., Chang C.C., Chen R.M. Nitric oxide from both exogenous and endogenous sources activates mitochondria-dependent events and induces insults to human chondrocytes. J. Cell. Biochem. 2007, 101:1520-1531.
110. Brandt K.D. Response of joint structures to inactivity and to reloading after immobilization. Arthritis Rheum. 2003, 49:267-271.
111. Smith R.L., Carter D.R., Schurman D.J. Pressure and shear differentially alter human articular chondrocyte metabolism: a review. Clin. Orthop. Relat. Res. 2004, S89-S95.
112. Friederich J.A., Butterworth J.F.t. Sodium nitroprusside: twenty years and counting. Anesth. Analg. 1995, 81:152-162.
113. Johnson K., Jung A., Murphy A., Andreyev A., Dykens J., Terkeltaub R. Mitochondrial oxidative phosphorylation is a downstream regulator of nitric oxide effects on chondrocyte matrix synthesis and mineralization. Arthritis Rheum. 2000, 43:1560-1570.
114. Migita K., Yamasaki S., Kita M., Ida H., Shibatomi K., Kawakami A., Aoyagi T., Eguchi K. Nitric oxide protects cultured rheumatoid synovial cells from Fas-induced apoptosis by inhibiting caspase-3. Immunology 2001, 103:362-367.
115. Kuhn K., Shikhman A.R., Lotz M. Role of nitric oxide, reactive oxygen species, and p38 MAP kinase in the regulation of human chondrocyte apoptosis. J. Cell. Physiol. 2003, 197:379-387.
116. Liang Q., Wang X.P., Chen T.S. Resveratrol protects rabbit articular chondrocyte against sodium nitroprusside-induced apoptosis via scavenging ROS. Apoptosis 2014, 19:1354-1363.
117. Roos W.P., Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol. Med. 2006, 12:440-450.
118. Chen A.F., Davies C.M., De Lin M., Fermor B. Oxidative DNA damage in osteoarthritic porcine articular cartilage. J. Cell. Physiol. 2008, 217:828-833.
119. Aigner T., Hemmel M., Neureiter D., Gebhard P.M., Zeiler G., Kirchner T., McKenna L. Apoptotic cell death is not a widespread phenomenon in normal aging and osteoarthritis human articular knee cartilage: a study of proliferation, programmed cell death (apoptosis), and viability of chondrocytes in normal and osteoarthritic human knee cartilage. Arthritis Rheum. 2001, 44:1304-1312.
120. Kim H.A., Lee Y.J., Seong S.C., Choe K.W., Song Y.W. Apoptotic chondrocyte death in human osteoarthritis. J. Rheumatol. 2000, 27:455-462.
121. Kouri J.B., Aguilera J.M., Reyes J., Lozoya K.A., Gonzalez S. Apoptotic chondrocytes from osteoarthrotic human articular cartilage and abnormal calcification of subchondral bone. J. Rheumatol. 2000, 27:1005-1019.
122. Grishko V.I., Ho R., Wilson G.L., Pearsall A.W.t. Diminished mitochondrial DNA integrity and repair capacity in OA chondrocytes. Osteoarthr. Cartil. 2009, 17:107-113.
123. Boyd C.S., Cadenas E. Nitric oxide and cell signaling pathways in mitochondrial-dependent apoptosis. Biol. Chem. 2002, 383:411-423.
124. Moncada S., Erusalimsky J.D. Does nitric oxide modulate mitochondrial energy generation and apoptosis?. Nat. Rev. Mol. Cell Biol. 2002, 3:214-220.
125. Yasuhara R., Miyamoto Y., Akaike T., Akuta T., Nakamura M., Takami M., Morimura N., Yasu K., Kamijo R. Interleukin-1beta induces death in chondrocyte-like ATDC5 cells through mitochondrial dysfunction and energy depletion in a reactive nitrogen and oxygen species-dependent manner. Biochem. J. 2005, 389:315-323.
126. Loeser R.F. Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthr. Cartil. 2009, 17:971-979.
127. Martin J.A., Buckwalter J.A. Telomere erosion and senescence in human articular cartilage chondrocytes. J. Gerontol. A Biol. Sci. Med. Sci. 2001, 56:B172-B179.
128. Yudoh K., Nguyen T., Nakamura H., Hongo-Masuko K., Kato T., Nishioka K. Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function. Arthritis Res. Ther. 2005, 7:R380-R391.
129. Martin J.A., Klingelhutz A.J., Moussavi-Harami F., Buckwalter J.A. Effects of oxidative damage and telomerase activity on human articular cartilage chondrocyte senescence. J. Gerontol. A Biol. Sci. Med. Sci. 2004, 59:324-337.
130. Dai S.M., Shan Z.Z., Nakamura H., Masuko-Hongo K., Kato T., Nishioka K., Yudoh K. Catabolic stress induces features of chondrocyte senescence through overexpression of caveolin 1: possible involvement of caveolin 1-induced down-regulation of articular chondrocytes in the pathogenesis of osteoarthritis. Arthritis Rheum. 2006, 54:818-831.
131. Zushi S., Akagi M., Kishimoto H., Teramura T., Sawamura T., Hamanishi C. Induction of bovine articular chondrocyte senescence with oxidized low-density lipoprotein through lectin-like oxidized low-density lipoprotein receptor 1. Arthritis Rheum. 2009, 60:3007-3016.
132. Court R., Chapman L., Fairall L., Rhodes D. How the human telomeric proteins TRF1 and TRF2 recognize telomeric DNA: a view from high-resolution crystal structures. EMBO Rep. 2005, 6:39-45.
133. Thacker J., Zdzienicka M.Z. The mammalian XRCC genes: their roles in DNA repair and genetic stability. DNA Repair (Amst) 2003, 2:655-672.
134. Guarente L. Diverse and dynamic functions of the Sir silencing complex. Nat. Genet. 1999, 23:281-285.
135. Brandl A., Hartmann A., Bechmann V., Graf B., Nerlich M., Angele P. Oxidative stress induces senescence in chondrocytes. J. Orthop. Res. 2011, 29:1114-1120.
136. Loeser R.F., Yammani R.R., Carlson C.S., Chen H., Cole A., Im H.J., Bursch L.S., Yan S.D. Articular chondrocytes express the receptor for advanced glycation end products: potential role in osteoarthritis. Arthritis Rheum. 2005, 52:2376-2385.
137. Huang C.Y., Hung L.F., Liang C.C., Ho L.J. COX-2 and iNOS are critical in advanced glycation end product-activated chondrocytes in vitro. Eur. J. Clin. Investig. 2009, 39:417-428.
138. Nah S.S., Choi I.Y., Lee C.K., Oh J.S., Kim Y.G., Moon H.B., Yoo B. Effects of advanced glycation end products on the expression of COX-2, PGE2 and NO in human osteoarthritic chondrocytes. Rheumatology (Oxford) 2008, 47:425-431.
139. Verzijl N., DeGroot J., Ben Z.C., Brau-Benjamin O., Maroudas A., Bank R.A., Mizrahi J., Schalkwijk C.G., Thorpe S.R., Baynes J.W., Bijlsma J.W., Lafeber F.P., TeKoppele J.M. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. Arthritis Rheum. 2002, 46:114-123.
140. Yammani R.R., Carlson C.S., Bresnick A.R., Loeser R.F. Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: role of the receptor for advanced glycation end products. Arthritis Rheum. 2006, 54:2901-2911.
141. Gao Y., Liu S., Huang J., Guo W., Chen J., Zhang L., Zhao B., Peng J., Wang A., Wang Y., Xu W., Lu S., Yuan M., Guo Q. The ECM-cell interaction of cartilage extracellular matrix on chondrocytes. Biomed. Res. Int. 2014, 2014:648459.
142. Hauselmann H.J., Stefanovic-Racic M., Michel B.A., Evans C.H. Differences in nitric oxide production by superficial and deep human articular chondrocytes: implications for proteoglycan turnover in inflammatory joint diseases. J. Immunol. 1998, 160:1444-1448.
143. Baker M.S., Feigan J., Lowther D.A. The mechanism of chondrocyte hydrogen peroxide damage. Depletion of intracellular ATP due to suppression of glycolysis caused by oxidation of glyceraldehyde-3-phosphate dehydrogenase. J. Rheumatol. 1989, 16:7-14.
144. Oh M., Fukuda K., Asada S., Yasuda Y., Tanaka S. Concurrent generation of nitric oxide and superoxide inhibits proteoglycan synthesis in bovine articular chondrocytes: involvement of peroxynitrite. J. Rheumatol. 1998, 25:2169-2174.
145. Starkman B.G., Cravero J.D., Delcarlo M., Loeser R.F. IGF-I stimulation of proteoglycan synthesis by chondrocytes requires activation of the PI 3-kinase pathway but not ERK MAPK. Biochem. J. 2005, 389:723-729.
146. Taskiran D., Stefanovic-Racic M., Georgescu H., Evans C. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biochem. Biophys. Res. Commun. 1994, 200:142-148.
147. Fioravanti A., Cantarini L., Chellini F., Manca D., Paccagnini E., Marcolongo R., Collodel G. Effect of hyaluronic acid (MW 500-730 kDa) on proteoglycan and nitric oxide production in human osteoarthritic chondrocyte cultures exposed to hydrostatic pressure. Osteoarthr. Cartil. 2005, 13:688-696.
148. Goodwin W., McCabe D., Sauter E., Reese E., Walter M., Buckwalter J.A., Martin J.A. Rotenone prevents impact-induced chondrocyte death. J. Orthop. Res. 2010, 28:1057-1063.
149. Yu S.M., Kim S.J. Production of reactive oxygen species by withaferin A causes loss of type collagen expression and COX-2 expression through the PI3K/Akt, p38, and JNK pathways in rabbit articular chondrocytes. Exp. Cell Res. 2013, 319:2822-2834.
150. Mateos J., De la Fuente A., Lesende-Rodriguez I., Fernandez-Pernas P., Arufe M.C., Blanco F.J. Lamin A deregulation in human mesenchymal stem cells promotes an impairment in their chondrogenic potential and imbalance in their response to oxidative stress. Stem Cell Res. 2013, 11:1137-1148.
151. Frenkel S.R., Clancy R.M., Ricci J.L., Di Cesare P.E., Rediske J.J., Abramson S.B. Effects of nitric oxide on chondrocyte migration, adhesion, and cytoskeletal assembly. Arthritis Rheum. 1996, 39:1905-1912.
152. Greenwald R.A., Moy W.W. Inhibition of collagen gelation by action of the superoxide radical. Arthritis Rheum. 1979, 22:251-259.
153. Stowe D.F., Camara A.K. Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function. Antioxid. Redox Signal. 2009, 11:1373-1414.
154. Monboisse J.C., Braquet P., Randoux A., Borel J.P. Non-enzymatic degradation of acid-soluble calf skin collagen by superoxide ion: protective effect of flavonoids. Biochem. Pharmacol. 1983, 32:53-58.
155. Murrell G.A., Jang D., Williams R.J. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem. Biophys. Res. Commun. 1995, 206:15-21.
156. Burkhardt H., Schwingel M., Menninger H., Macartney H.W., Tschesche H. Oxygen radicals as effectors of cartilage destruction. Direct degradative effect on matrix components and indirect action via activation of latent collagenase from polymorphonuclear leukocytes. Arthritis Rheum. 1986, 29:379-387.
157. Michaelis J., Vissers M.C., Winterbourn C.C. Different effects of hypochlorous acid on human neutrophil metalloproteinases: activation of collagenase and inactivation of collagenase and gelatinase. Arch. Biochem. Biophys. 1992, 292:555-562.
158. Shabani F., McNeil J., Tippett L. The oxidative inactivation of tissue inhibitor of metalloproteinase-1 (TIMP-1) by hypochlorous acid (HOCI) is suppressed by anti-rheumatic drugs. Free Radic. Res. 1998, 28:115-123.
159. Ridnour L.A., Windhausen A.N., Isenberg J.S., Yeung N., Thomas D.D., Vitek M.P., Roberts D.D., Wink D.A. Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:16898-16903.
160. Fay J., Varoga D., Wruck C.J., Kurz B., Goldring M.B., Pufe T. Reactive oxygen species induce expression of vascular endothelial growth factor in chondrocytes and human articular cartilage explants. Arthritis Res. Ther. 2006, 8:R189.
161. Ahmad R., Sylvester J., Ahmad M., Zafarullah M. Involvement of H-Ras and reactive oxygen species in proinflammatory cytokine-induced matrix metalloproteinase-13 expression in human articular chondrocytes. Arch. Biochem. Biophys. 2011, 507:350-355.
162. Wood S.T., Long D.L., Reisz J.A., Yammani R.R., Burke E.A., Klomsiri C., Poole L.B., Furdui C.M., Loeser R.F. Cysteine-mediated redox regulation of cell signaling in chondrocytes stimulated with fibronectin fragments. Arthritis Rheum. 2015.
163. Del Carlo M., Schwartz D., Erickson E.A., Loeser R.F. Endogenous production of reactive oxygen species is required for stimulation of human articular chondrocyte matrix metalloproteinase production by fibronectin fragments. Free Radic. Biol. Med. 2007, 42:1350-1358.
164. Tiku M.L., Shah R., Allison G.T. Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation. Possible role in cartilage aging and the pathogenesis of osteoarthritis. J. Biolumin. Chemilumin. 2000, 275:20069-20076.
165. Surapaneni K.M., Venkataramana G. Status of lipid peroxidation, glutathione, ascorbic acid, vitamin E and antioxidant enzymes in patients with osteoarthritis. Indian J. Med. Sci. 2007, 61:9-14.
166. Shah R., Raska K., Tiku M.L. The presence of molecular markers of in vivo lipid peroxidation in osteoarthritic cartilage: a pathogenic role in osteoarthritis. Arthritis Rheum. 2005, 52:2799-2807.
167. Sarban S., Kocyigit A., Yazar M., Isikan U.E. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin. Biochem. 2005, 38:981-986.
168. Suantawee T., Tantavisut S., Adisakwattana S., Tanavalee A., Yuktanandana P., Anomasiri W., Deepaisarnsakul B., Honsawek S. Oxidative stress, vitamin e, and antioxidant capacity in knee osteoarthritis. J. Clin. Diagn. Res. 2013, 7:1855-1859.
169. Morquette B., Shi Q., Lavigne P., Ranger P., Fernandes J.C., Benderdour M. Production of lipid peroxidation products in osteoarthritic tissues: new evidence linking 4-hydroxynonenal to cartilage degradation. Arthritis Rheum. 2006, 54:271-281.
170. Vaillancourt F., Morquette B., Shi Q., Fahmi H., Lavigne P., Di Battista J.A., Fernandes J.C., Benderdour M. Differential regulation of cyclooxygenase-2 and inducible nitric oxide synthase by 4-hydroxynonenal in human osteoarthritic chondrocytes through ATF-2/CREB-1 transactivation and concomitant inhibition of NF-kappaB signaling cascade. J. Cell. Biochem. 2007, 100:1217-1231.
171. Nakagawa T., Yasuda T., Hoshikawa H., Shimizu M., Kakinuma T., Chen M., Masaki T., Nakamura T., Sawamura T. LOX-1 expressed in cultured rat chondrocytes mediates oxidized LDL-induced cell death-possible role of dephosphorylation of Akt. Biochem. Biophys. Res. Commun. 2002, 299:91-97.
172. Nishimura S., Akagi M., Yoshida K., Hayakawa S., Sawamura T., Munakata H., Hamanishi C. Oxidized low-density lipoprotein (ox-LDL) binding to lectin-like ox-LDL receptor-1 (LOX-1) in cultured bovine articular chondrocytes increases production of intracellular reactive oxygen species (ROS) resulting in the activation of NF-kappaB. Osteoarthr. Cartil. 2004, 12:568-576.
173. Simopoulou T., Malizos K.N., Tsezou A. Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) expression in human articular chondrocytes. Clin. Exp. Rheumatol. 2007, 25:605-612.
174. Akagi M., Kanata S., Mori S., Itabe H., Sawamura T., Hamanishi C. Possible involvement of the oxidized low-density lipoprotein/lectin-like oxidized low-density lipoprotein receptor-1 system in pathogenesis and progression of human osteoarthritis. Osteoarthr. Cartil. 2007, 15:281-290.
175. Nakagawa T., Akagi M., Hoshikawa H., Chen M., Yasuda T., Mukai S., Ohsawa K., Masaki T., Nakamura T., Sawamura T. Lectin-like oxidized low-density lipoprotein receptor 1 mediates leukocyte infiltration and articular cartilage destruction in rat zymosan-induced arthritis. Arthritis Rheum. 2002, 46:2486-2494.
176. Kishimoto H., Akagi M., Zushi S., Teramura T., Onodera Y., Sawamura T., Hamanishi C. Induction of hypertrophic chondrocyte-like phenotypes by oxidized LDL in cultured bovine articular chondrocytes through increase in oxidative stress. Osteoarthr. Cartil. 2010, 18:1284-1290.
177. van der Kraan P.M., van den Berg W.B. Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration?. Osteoarthr. Cartil. 2012, 20:223-232.
178. Kim K.S., Choi H.W., Yoon H.E., Kim I.Y. Reactive oxygen species generated by NADPH oxidase 2 and 4 are required for chondrogenic differentiation. J. Biolumin. Chemilumin. 2010, 285:40294-40302.
179. Kim J., Xu M., Xo R., Mates A., Wilson G.L., Pearsall A.W.t., Grishko V. Mitochondrial DNA damage is involved in apoptosis caused by pro-inflammatory cytokines in human OA chondrocytes. Osteoarthr. Cartil. 2010, 18:424-432.
180. Lopez-Armada M.J., Carames B., Martin M.A., Cillero-Pastor B., Lires-Dean M., Fuentes-Boquete I., Arenas J., Blanco F.J. Mitochondrial activity is modulated by TNFalpha and IL-1beta in normal human chondrocyte cells. Osteoarthr. Cartil. 2006, 14:1011-1022.
181. Golden T.R., Melov S. Mitochondrial DNA mutations, oxidative stress, and aging. Mech. Ageing Dev. 2001, 122:1577-1589.
182. Chung S.S., Weindruch R., Schwarze S.R., McKenzie D.I., Aiken J.M. Multiple age-associated mitochondrial DNA deletions in skeletal muscle of mice. Aging (Milano) 1994, 6:193-200.
183. Zhang C., Baumer A., Maxwell R.J., Linnane A.W., Nagley P. Multiple mitochondrial DNA deletions in an elderly human individual. FEBS Lett. 1992, 297:34-38.
184. Welle S., Bhatt K., Shah B., Needler N., Delehanty J.M., Thornton C.A. Reduced amount of mitochondrial DNA in aged human muscle. J. Appl. Physiol. 1985, 94(2003):1479-1484.
185. Maneiro E., Martin M.A., de Andres M.C., Lopez-Armada M.J., Fernandez-Sueiro J.L., del Hoyo P., Galdo F., Arenas J., Blanco F.J. Mitochondrial respiratory activity is altered in osteoarthritic human articular chondrocytes. Arthritis Rheum. 2003, 48:700-708.
186. Reed K.N., Wilson G., Pearsall A., Grishko V.I. The role of mitochondrial reactive oxygen species in cartilage matrix destruction. Mol. Cell. Biochem. 2014, 397:195-201.
187. Vaamonde-Garcia C., Riveiro-Naveira R.R., Valcarcel-Ares M.N., Hermida-Carballo L., Blanco F.J., Lopez-Armada M.J. Mitochondrial dysfunction increases inflammatory responsiveness to cytokines in normal human chondrocytes. Arthritis Rheum. 2012, 64:2927-2936.
188. Chang J., Wang W., Zhang H., Hu Y., Wang M., Yin Z. The dual role of autophagy in chondrocyte responses in the pathogenesis of articular cartilage degeneration in osteoarthritis. Int. J. Mol. Med. 2013, 32:1311-1318.
189. Li Y.S., Zhang F.J., Zeng C., Luo W., Xiao W.F., Gao S.G., Lei G.H. Autophagy in osteoarthritis. Joint Bone Spine 2015.
190. Shen C., Cai G.Q., Peng J.P., Chen X.D. Autophagy protects chondrocytes from glucocorticoids-induced apoptosis via ROS/Akt/FOXO3 signaling. Osteoarthr. Cartil. 2015, 23:2279-2287.
191. Sasaki H., Takayama K., Matsushita T., Ishida K., Kubo S., Matsumoto T., Fujita N., Oka S., Kurosaka M., Kuroda R. Autophagy modulates osteoarthritis-related gene expression in human chondrocytes. Arthritis Rheum. 2012, 64:1920-1928.
192. Shen C., Chen X.D., Yan J. Nitric oxide inhibits autophagy in human chondrocytes: comment on the article by Sasaki et al. Arthritis Rheum. 2013, 65:287-288.
193. Hancock C.M., Riegger-Krugh C. Modulation of pain in osteoarthritis: the role of nitric oxide. Clin. J. Pain 2008, 24:353-365.
194. Wang Z.Q., Porreca F., Cuzzocrea S., Galen K., Lightfoot R., Masini E., Muscoli C., Mollace V., Ndengele M., Ischiropoulos H., Salvemini D. A newly identified role for superoxide in inflammatory pain. J. Pharmacol. Exp. Ther. 2004, 309:869-878.
195. Bates E.J., Lowther D.A., Handley C.J. Oxygen free-radicals mediate an inhibition of proteoglycan synthesis in cultured articular cartilage. Ann. Rheum. Dis. 1984, 43:462-469.
196. Chenevier-Gobeaux C., Lemarechal H., Bonnefont-Rousselot D., Poiraudeau S., Ekindjian O.G., Borderie D. Superoxide production and NADPH oxidase expression in human rheumatoid synovial cells: regulation by interleukin-1beta and tumour necrosis factor-alpha. Inflamm. Res. 2006, 55:483-490.
197. McInnes I.B., Leung B.P., Field M., Wei X.Q., Huang F.P., Sturrock R.D., Kinninmonth A., Weidner J., Mumford R., Liew F.Y. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J. Exp. Med. 1996, 184:1519-1524.
198. Stefanovic-Racic M., Stadler J., Georgescu H.I., Evans C.H. Nitric oxide synthesis and its regulation by rabbit synoviocytes. J. Rheumatol. 1994, 21:1892-1898.
199. Chenevier-Gobeaux C., Simonneau C., Therond P., Bonnefont-Rousselot D., Poiraudeau S., Ekindjian O.G., Borderie D. Implication of cytosolic phospholipase A2 (cPLA2) in the regulation of human synoviocyte NADPH oxidase (Nox2) activity. Life Sci. 2007, 81:1050-1058.
200. Chenevier-Gobeaux C., Simonneau C., Lemarechal H., Bonnefont-Rousselot D., Poiraudeau S., Rannou F., Ekindjian O.G., Anract P., Borderie D. Effect of hypoxia/reoxygenation on the cytokine-induced production of nitric oxide and superoxide anion in cultured osteoarthritic synoviocytes. Osteoarthr. Cartil. 2013, 21:874-881.
201. Schneider N., Mouithys-Mickalad A.L., Lejeune J.P., Deby-Dupont G.P., Hoebeke M., Serteyn D.A. Synoviocytes, not chondrocytes, release free radicals after cycles of anoxia/re-oxygenation. Biochem. Biophys. Res. Commun. 2005, 334:669-673.
202. Grigolo B., Roseti L., Fiorini M., Facchini A. Enhanced lipid peroxidation in synoviocytes from patients with osteoarthritis. J. Rheumatol. 2003, 30:345-347.
203. Marok R., Winyard P.G., Coumbe A., Kus M.L., Gaffney K., Blades S., Mapp P.I., Morris C.J., Blake D.R., Kaltschmidt C., Baeuerle P.A. Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. Arthritis Rheum. 1996, 39:583-591.
204. Sandhu J.K., Robertson S., Birnboim H.C., Goldstein R. Distribution of protein nitrotyrosine in synovial tissues of patients with rheumatoid arthritis and osteoarthritis. J. Rheumatol. 2003, 30:1173-1181.
205. Farrell A.J., Blake D.R., Palmer R.M., Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann. Rheum. Dis. 1992, 51:1219-1222.
206. Khan F., Siddiqui A.A. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus. Clin. Chim. Acta 2006, 370:100-107.
207. Tsai C.H., Chiang Y.C., Chen H.T., Huang P.H., Hsu H.C., Tang C.H. High glucose induces vascular endothelial growth factor production in human synovial fibroblasts through reactive oxygen species generation. Biochim. Biophys. Acta 2013, 1830:2649-2658.
208. Cedergren J., Forslund T., Sundqvist T., Skogh T. Inducible nitric oxide synthase is expressed in synovial fluid granulocytes. Clin. Exp. Immunol. 2002, 130:150-155.
209. Sasaki K., Hattori T., Fujisawa T., Takahashi K., Inoue H., Takigawa M. Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes. J. Biochem. 1998, 123:431-439.
210. Kheradmand F., Werner E., Tremble P., Symons M., Werb Z. Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change. Science 1998, 280:898-902.
211. Yu H., Ye W.B., Zhong Z.M., Ding R.T., Chen J.T. Effect of advanced oxidation protein products on articular cartilage and synovium in a rabbit osteoarthritis model. Orthop. Surg. 2015, 7:161-167.
212. Veihelmann A., Landes J., Hofbauer A., Dorger M., Refior H.J., Messmer K., Krombach F. Exacerbation of antigen-induced arthritis in inducible nitric oxide synthase-deficient mice. Arthritis Rheum. 2001, 44:1420-1427.
213. Galleron S., Borderie D., Ponteziere C., Lemarechal H., Jambou M., Roch-Arveiller M., Ekindjian O.G., Cals M.J. Reactive oxygen species induce apoptosis of synoviocytes in vitro. Alpha-tocopherol provides no protection. Cell Biol. Int. 1999, 23:637-642.
214. Cillero-Pastor B., Martin M.A., Arenas J., Lopez-Armada M.J., Blanco F.J. Effect of nitric oxide on mitochondrial activity of human synovial cells. BMC Musculoskelet. Disord. 2011, 12:42.
215. Borderie D., Hilliquin P., Hernvann A., Lemarechal H., Menkes C.J., Ekindjian O.G. Apoptosis induced by nitric oxide is associated with nuclear p53 protein expression in cultured osteoarthritic synoviocytes. Osteoarthr. Cartil. 1999, 7:203-213.
216. Jovanovic D.V., Mineau F., Notoya K., Reboul P., Martel-Pelletier J., Pelletier J.P. Nitric oxide induced cell death in human osteoarthritic synoviocytes is mediated by tyrosine kinase activation and hydrogen peroxide and/or superoxide formation. J. Rheumatol. 2002, 29:2165-2175.
217. Shi Q., Vaillancourt F., Cote V., Fahmi H., Lavigne P., Afif H., Di Battista J.A., Fernandes J.C., Benderdour M. Alterations of metabolic activity in human osteoarthritic osteoblasts by lipid peroxidation end product 4-hydroxynonenal. Arthritis Res. Ther. 2006, 8:R159.
218. Cake M.A., Read R.A., Appleyard R.C., Hwa S.Y., Ghosh P. The nitric oxide donor glyceryl trinitrate increases subchondral bone sclerosis and cartilage degeneration following ovine meniscectomy. Osteoarthr. Cartil. 2004, 12:974-981.
219. Evans D.M., Ralston S.H. Nitric oxide and bone. J. Bone Miner. Res. 1996, 11:300-305.
220. Englund M., Guermazi A., Lohmander S.L. The role of the meniscus in knee osteoarthritis: a cause or consequence?. Radiol. Clin. N. Am. 2009, 47:703-712.
221. Shen C., Yan J., Erkocak O.F., Zheng X.F., Chen X.D. Nitric oxide inhibits autophagy via suppression of JNK in meniscal cells. Rheumatology (Oxford) 2014, 53:1022-1033.
222. Hashimoto S., Takahashi K., Ochs R.L., Coutts R.D., Amiel D., Lotz M. Nitric oxide production and apoptosis in cells of the meniscus during experimental osteoarthritis. Arthritis Rheum. 1999, 42:2123-2131.
223. Ioan-Facsinay A., Kloppenburg M. An emerging player in knee osteoarthritis: the infrapatellar fat pad. Arthritis Res. Ther. 2013, 15:225.
224. Aroor A.R., DeMarco V.G. Oxidative stress and obesity: the chicken or the egg?. Diabetes 2014, 63:2216-2218.
225. Poole A.R. Can serum biomarker assays measure the progression of cartilage degeneration in osteoarthritis?. Arthritis Rheum. 2002, 46:2549-2552.
226. Regan E., Flannelly J., Bowler R., Tran K., Nicks M., Carbone B.D., Glueck D., Heijnen H., Mason R., Crapo J. Extracellular superoxide dismutase and oxidant damage in osteoarthritis. Arthritis Rheum. 2005, 52:3479-3491.
227. Mathy-Hartert M., Hogge L., Sanchez C., Deby-Dupont G., Crielaard J.M., Henrotin Y. Interleukin-1beta and interleukin-6 disturb the antioxidant enzyme system in bovine chondrocytes: a possible explanation for oxidative stress generation. Osteoarthr. Cartil. 2008, 16:756-763.
228. Mazzetti I., Grigolo B., Pulsatelli L., Dolzani P., Silvestri T., Roseti L., Meliconi R., Facchini A. Differential roles of nitric oxide and oxygen radicals in chondrocytes affected by osteoarthritis and rheumatoid arthritis. Clin. Sci. (Lond.) 2001, 101:593-599.
229. Huie R.E., Padmaja S. The reaction of no with superoxide. Free Radic. Res. Commun. 1993, 18:195-199.
230. Scott J.L., Gabrielides C., Davidson R.K., Swingler T.E., Clark I.M., Wallis G.A., Boot-Handford R.P., Kirkwood T.B., Taylor R.W., Young D.A. Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease. Ann. Rheum. Dis. 2010, 69:1502-1510.
231. Jallali N., Ridha H., Thrasivoulou C., Underwood C., Butler P.E., Cowen T. Vulnerability to ROS-induced cell death in ageing articular cartilage: the role of antioxidant enzyme activity. Osteoarthr. Cartil. 2005, 13:614-622.
232. Oberley T.D., Verwiebe E., Zhong W., Kang S.W., Rhee S.G. Localization of the thioredoxin system in normal rat kidney. Free Radic. Biol. Med. 2001, 30:412-424.
233. Wang M.X., Wei A., Yuan J., Trickett A., Knoops B., Murrell G.A. Expression and regulation of peroxiredoxin 5 in human osteoarthritis. FEBS Lett. 2002, 531:359-362.
234. Ma Y., Li R., Zhang Y., Zhou L., Dai Y. Knockdown of peroxiredoxin 5 inhibits the growth of osteoarthritic chondrocytes via upregulating Wnt/beta-catenin signaling. Free Radic. Biol. Med. 2014, 76:251-260.
235. Cai D., Yin S., Yang J., Jiang Q., Cao W. Histone deacetylase inhibition activates Nrf2 and protects against osteoarthritis. Arthritis Res. Ther. 2015, 17:269.
236. Sun J., Hoshino H., Takaku K., Nakajima O., Muto A., Suzuki H., Tashiro S., Takahashi S., Shibahara S., Alam J., Taketo M.M., Yamamoto M., Igarashi K. Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO J. 2002, 21:5216-5224.
237. Ochiai S., Mizuno T., Deie M., Igarashi K., Hamada Y., Ochi M. Oxidative stress reaction in the meniscus of Bach 1 deficient mice: potential prevention of meniscal degeneration. J. Orthop. Res. 2008, 26:894-898.
238. Hercberg S., Galan P., Preziosi P., Bertrais S., Mennen L., Malvy D., Roussel A.M., Favier A., Briancon S. The SU.VI.MAX study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch. Intern. Med. 2004, 164:2335-2342.
239. Chang Z., Huo L., Li P., Wu Y., Zhang P. Ascorbic acid provides protection for human chondrocytes against oxidative stress. Mol. Med. Rep. 2015.
240. Kraus V.B., Huebner J.L., Stabler T., Flahiff C.M., Setton L.A., Fink C., Vilim V., Clark A.G. Ascorbic acid increases the severity of spontaneous knee osteoarthritis in a guinea pig model. Arthritis Rheum. 2004, 50:1822-1831.
241. Ohrvall M., Sundlof G., Vessby B. Gamma, but not alpha, tocopherol levels in serum are reduced in coronary heart disease patients. J. Intern. Med. 1996, 239:111-117.
242. Bhattacharya I., Saxena R., Gupta V. Efficacy of vitamin E in knee osteoarthritis management of North Indian geriatric population. Ther. Adv. Musculoskelet. Disord. 2012, 4:11-19.
243. McAlindon T.E., Jacques P., Zhang Y., Hannan M.T., Aliabadi P., Weissman B., Rush D., Levy D., Felson D.T. Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis?. Arthritis Rheum. 1996, 39:648-656.
244. Brand C., Snaddon J., Bailey M., Cicuttini F. Vitamin E is ineffective for symptomatic relief of knee osteoarthritis: a six month double blind, randomised, placebo controlled study. Ann. Rheum. Dis. 2001, 60:946-949.
245. Chaganti R.K., Tolstykh I., Javaid M.K., Neogi T., Torner J., Curtis J., Jacques P., Felson D., Lane N.E., Nevitt M.C. High plasma levels of vitamin C and E are associated with incident radiographic knee osteoarthritis. Osteoarthr. Cartil. 2014, 22:190-196.
246. Wluka A.E., Stuckey S., Brand C., Cicuttini F.M. Supplementary vitamin E does not affect the loss of cartilage volume in knee osteoarthritis: a 2 year double blind randomized placebo controlled study. J. Rheumatol. 2002, 29:2585-2591.
247. Park H.S., Huh S.H., Kim Y., Shim J., Lee S.H., Park I.S., Jung Y.K., Kim I.Y., Choi E.J. Selenite negatively regulates caspase-3 through a redox mechanism. J. Biolumin. Chemilumin. 2000, 275:8487-8491.
248. Canter P.H., Wider B., Ernst E. The antioxidant vitamins A, C, E and selenium in the treatment of arthritis: a systematic review of randomized clinical trials. Rheumatology (Oxford) 2007, 46:1223-1233.
249. Rosenbaum C.C., O'Mathuna D.P., Chavez M., Shields K. Antioxidants and antiinflammatory dietary supplements for osteoarthritis and rheumatoid arthritis. Altern. Ther. Health Med. 2010, 16:32-40.
250. Lee J., Hong Y.S., Jeong J.H., Yang E.J., Jhun J.Y., Park M.K., Jung Y.O., Min J.K., Kim H.Y., Park S.H., Cho M.L. Coenzyme Q10 ameliorates pain and cartilage degradation in a rat model of osteoarthritis by regulating nitric oxide and inflammatory cytokines. PLoS One 2013, 8.
251. Sakata S., Hayashi S., Fujishiro T., Kawakita K., Kanzaki N., Hashimoto S., Iwasa K., Chinzei N., Kihara S., Haneda M., Ueha T., Nishiyama T., Kuroda R., Kurosaka M. Oxidative stress-induced apoptosis and matrix loss of chondrocytes is inhibited by eicosapentaenoic acid. J. Orthop. Res. 2015, 33:359-365.
252. Ribas G.S., Vargas C.R., Wajner M. l-Carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders. Gene 2014, 533:469-476.
253. Malek Mahdavi A., Mahdavi R., Kolahi S., Zemestani M., Vatankhah A.M. l-Carnitine supplementation improved clinical status without changing oxidative stress and lipid profile in women with knee osteoarthritis. Nutr. Res. 2015, 35:707-715.
254. Sato H., Takahashi T., Ide H., Fukushima T., Tabata M., Sekine F., Kobayashi K., Negishi M., Niwa Y. Antioxidant activity of synovial fluid, hyaluronic acid, and two subcomponents of hyaluronic acid. Synovial fluid scavenging effect is enhanced in rheumatoid arthritis patients. Arthritis Rheum. 1988, 31:63-71.
255. Moreland L.W. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res. Ther. 2003, 5:54-67.
256. Miki Y., Teramura T., Tomiyama T., Onodera Y., Matsuoka T., Fukuda K., Hamanishi C. Hyaluronan reversed proteoglycan synthesis inhibited by mechanical stress: possible involvement of antioxidant effect. Inflamm. Res. 2010, 59:471-477.
257. Aydogan N.H., Baydar M.L., Atay T., Perktas I., Baykal B.Y., Ozmeric A. The effect of arthroscopic surgery and intraarticular drug injection to the antioxidation system and lipid peroxidation at osteoarthritis of knee. Saudi Med. J. 2008, 29:397-402.
258. Yu C.J., Ko C.J., Hsieh C.H., Chien C.T., Huang L.H., Lee C.W., Jiang C.C. Proteomic analysis of osteoarthritic chondrocyte reveals the hyaluronic acid-regulated proteins involved in chondroprotective effect under oxidative stress. J. Proteome 2014, 99:40-53.
259. Mongkhon J.M., Thach M., Shi Q., Fernandes J.C., Fahmi H., Benderdour M. Sorbitol-modified hyaluronic acid reduces oxidative stress, apoptosis and mediators of inflammation and catabolism in human osteoarthritic chondrocytes. Inflamm. Res. 2014, 63:691-701.
260. Baret P., Septembre-Malaterre A., Rigoulet M., Lefebvre d'Hellencourt C., Priault M., Gonthier M.P., Devin A. Dietary polyphenols preconditioning protects 3T3-L1 preadipocytes from mitochondrial alterations induced by oxidative stress. Int. J. Biochem. Cell Biol. 2013, 45:167-174.
261. Shakibaei M., Csaki C., Nebrich S., Mobasheri A. Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochem. Pharmacol. 2008, 76:1426-1439.
262. Csaki C., Keshishzadeh N., Fischer K., Shakibaei M. Regulation of inflammation signalling by resveratrol in human chondrocytes in vitro. Biochem. Pharmacol. 2008, 75:677-687.
263. Dave M., Attur M., Palmer G., Al-Mussawir H.E., Kennish L., Patel J., Abramson S.B. The antioxidant resveratrol protects against chondrocyte apoptosis via effects on mitochondrial polarization and ATP production. Arthritis Rheum. 2008, 58:2786-2797.
264. Elmali N., Esenkaya I., Harma A., Ertem K., Turkoz Y., Mizrak B. Effect of resveratrol in experimental osteoarthritis in rabbits. Inflamm. Res. 2005, 54:158-162.
265. Liu F.C., Hung L.F., Wu W.L., Chang D.M., Huang C.Y., Lai J.H., Ho L.J. Chondroprotective effects and mechanisms of resveratrol in advanced glycation end products-stimulated chondrocytes. Arthritis Res. Ther. 2010, 12:R167.
266. Lei M., Wang J.G., Xiao D.M., Fan M., Wang D.P., Xiong J.Y., Chen Y., Ding Y., Liu S.L. Resveratrol inhibits interleukin 1beta-mediated inducible nitric oxide synthase expression in articular chondrocytes by activating SIRT1 and thereby suppressing nuclear factor-kappaB activity. Eur. J. Pharmacol. 2012, 674:73-79.
267. Singh R., Ahmed S., Islam N., Goldberg V.M., Haqqi T.M. Epigallocatechin-3-gallate inhibits interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor kappaB. Arthritis Rheum. 2002, 46:2079-2086.
268. Ahmed S., Rahman A., Hasnain A., Lalonde M., Goldberg V.M., Haqqi T.M. Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1 beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radic. Biol. Med. 2002, 33:1097-1105.
269. Andriamanalijaona R., Kypriotou M., Bauge C., Renard E., Legendre F., Raoudi M., Boumediene K., Gatto H., Monginoux P., Pujol J.P. Comparative effects of 2 antioxidants, selenomethionine and epigallocatechin-gallate, on catabolic and anabolic gene expression of articular chondrocytes. J. Rheumatol. 2005, 32:1958-1967.
270. Wen L., Qu T.B., Zhai K., Ding J., Hai Y., Zhou J.L. Gallic acid can play a chondroprotective role against AGE-induced osteoarthritis progression. J. Orthop. Sci. 2015, 20:734-741.
271. Facchini A., Cetrullo S., D'Adamo S., Guidotti S., Minguzzi M., Borzi R.M., Flamigni F. Hydroxytyrosol prevents increase of osteoarthritis markers in human chondrocytes treated with hydrogen peroxide or growth-related oncogene alpha. PLoS One 2014, 9.
272. Panahi Y., Alishiri G.H., Parvin S., Sahebkar A. Mitigation of systemic oxidative stress by curcuminoids in osteoarthritis: results of a randomized controlled trial. J. Diet. Suppl. 2015.
273. Woo Y.J., Joo Y.B., Jung Y.O., Ju J.H., Cho M.L., Oh H.J., Jhun J.Y., Park M.K., Park J.S., Kang C.M., Sung M.S., Park S.H., Kim H.Y., Min J.K. Grape seed proanthocyanidin extract ameliorates monosodium iodoacetate-induced osteoarthritis. Exp. Mol. Med. 2011, 43:561-570.
274. Shin H.C., Hwang H.J., Kang K.J., Lee B.H. An antioxidative and antiinflammatory agent for potential treatment of osteoarthritis from Ecklonia cava. Arch. Pharm. Res. 2006, 29:165-171.
275. Schreck R., Rieber P., Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 1991, 10:2247-2258.
276. Nakagawa S., Arai Y., Mazda O., Kishida T., Takahashi K.A., Sakao K., Saito M., Honjo K., Imanishi J., Kubo T. N-acetylcysteine prevents nitric oxide-induced chondrocyte apoptosis and cartilage degeneration in an experimental model of osteoarthritis. J. Orthop. Res. 2010, 28:156-163.
277. Roman-Blas J.A., Contreras-Blasco M.A., Largo R., Alvarez-Soria M.A., Castaneda S., Herrero-Beaumont G. Differential effects of the antioxidant n-acetylcysteine on the production of catabolic mediators in IL-1beta-stimulated human osteoarthritic synoviocytes and chondrocytes. Eur. J. Pharmacol. 2009, 623:125-131.
278. Yoon J.B., Kim S.J., Hwang S.G., Chang S., Kang S.S., Chun J.S. Non-steroidal anti-inflammatory drugs inhibit nitric oxide-induced apoptosis and dedifferentiation of articular chondrocytes independent of cyclooxygenase activity. J. Biolumin. Chemilumin. 2003, 278:15319-15325.
279. Tuzun S., Uzun H., Aydin S., Dinc A., Sipahi S., Topcuoglu M.A., Yucel R., Belce A. Effects of flurbiprofen and tiaprofenic acid on oxidative stress markers in osteoarthritis: a prospective, randomized, open-label, active- and placebo-controlled trial. Curr. Ther. Res. Clin. Exp. 2005, 66:335-344.
280. Ozgocmen S., Ardicoglu O., Erdogan H., Fadillioglu E., Gudul H. In vivo effect of celecoxib and tenoxicam on oxidant/anti-oxidant status of patients with knee osteoarthritis. Ann. Clin. Lab. Sci. 2005, 35:137-143.
281. Friesen J.A., Rodwell V.W. The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases. Genome Biol. 2004, 5:248.
282. Pathak N.N., Balaganur V., Lingaraju M.C., Kant V., Kumar D., Sharma A.K., Tandan S.K. Effect of atorvastatin, a HMG-CoA reductase inhibitor in monosodium iodoacetate-induced osteoarthritic pain: implication for osteoarthritis therapy. Pharmacol. Rep. 2015, 67:513-519.
283. Chang C.H., Hsu Y.M., Chen Y.C., Lin F.H., Sadhasivam S., Loo S.T., Savitha S. Anti-inflammatory effects of hydrophilic and lipophilic statins with hyaluronic acid against LPS-induced inflammation in porcine articular chondrocytes. J. Orthop. Res. 2014, 32:557-565.
284. Yoda M., Sakai T., Mitsuyama H., Hiraiwa H., Ishiguro N. Geranylgeranylacetone suppresses hydrogen peroxide-induced apoptosis of osteoarthritic chondrocytes. J. Orthop. Sci. 2011, 16:791-798.
285. Claassen H., Schunke M., Kurz B. Estradiol protects cultured articular chondrocytes from oxygen-radical-induced damage. Cell Tissue Res. 2005, 319:439-445.
286. Lim H.D., Kim Y.S., Ko S.H., Yoon I.J., Cho S.G., Chun Y.H., Choi B.J., Kim E.C. Cytoprotective and anti-inflammatory effects of melatonin in hydrogen peroxide-stimulated CHON-001 human chondrocyte cell line and rabbit model of osteoarthritis via the SIRT1 pathway. J. Pineal Res. 2012, 53:225-237.
287. Jeong J.H., Moon S.J., Jhun J.Y., Yang E.J., Cho M.L., Min J.K. Eupatilin exerts antinociceptive and chondroprotective properties in a rat model of osteoarthritis by downregulating oxidative damage and catabolic activity in chondrocytes. PLoS One 2015, 10.
288. Maghsoumi-Norouzabad L., Alipoor B., Abed R., Eftekhar Sadat B., Mesgari-Abbasi M., Asghari Jafarabadi M. Effects of Arctium lappa L. (Burdock) root tea on inflammatory status and oxidative stress in patients with knee osteoarthritis. Int. J. Rheum. Dis. 2014.
289. Chen M.P., Yang S.H., Chou C.H., Yang K.C., Wu C.C., Cheng Y.H., Lin F.H. The chondroprotective effects of ferulic acid on hydrogen peroxide-stimulated chondrocytes: inhibition of hydrogen peroxide-induced pro-inflammatory cytokines and metalloproteinase gene expression at the mRNA level. Inflamm. Res. 2010, 59:587-595.
290. Jeong H.J., Koo H.N., Na H.J., Kim M.S., Hong S.H., Eom J.W., Kim K.S., Shin T.Y., Kim H.M. Inhibition of TNF-alpha and IL-6 production by Aucubin through blockade of NF-kappaB activation RBL-2H3 mast cells. Cytokine 2002, 18:252-259.
291. Wang S.N., Xie G.P., Qin C.H., Chen Y.R., Zhang K.R., Li X., Wu Q., Dong W.Q., Yang J., Yu B. Aucubin prevents interleukin-1 beta induced inflammation and cartilage matrix degradation via inhibition of NF-kappaB signaling pathway in rat articular chondrocytes. Int. Immunopharmacol. 2015, 24:408-415.
292. Yudoh K., Shishido K., Murayama H., Yano M., Matsubayashi K., Takada H., Nakamura H., Masuko K., Kato T., Nishioka K. Water-soluble C60 fullerene prevents degeneration of articular cartilage in osteoarthritis via down-regulation of chondrocyte catabolic activity and inhibition of cartilage degeneration during disease development. Arthritis Rheum. 2007, 56:3307-3318.
293. McCord J.M., Edeas M.A. SOD, oxidative stress and human pathologies: a brief history and a future vision. Biomed. Pharmacother. 2005, 59:139-142.
294. Di Cesare Mannelli L., Bani D., Bencini A., Brandi M.L., Calosi L., Cantore M., Carossino A.M., Ghelardini C., Valtancoli B., Failli P. Therapeutic effects of the superoxide dismutase mimetic compound MnIIMe2DO2A on experimental articular pain in rats. Mediat. Inflamm. 2013, 2013:905360.
295. Cuzzocrea S., Mazzon E., di Paola R., Genovese T., Muia C., Caputi A.P., Salvemini D. Synergistic interaction between methotrexate and a superoxide dismutase mimetic: pharmacologic and potential clinical significance. Arthritis Rheum. 2005, 52:3755-3760.
296. Cuzzocrea S., Mazzon E., Paola R.D., Genovese T., Muia C., Caputi A.P., Salvemini D. Effects of combination M40403 and dexamethasone therapy on joint disease in a rat model of collagen-induced arthritis. Arthritis Rheum. 2005, 52:1929-1940.
297. Rousset F., Nguyen M.V., Grange L., Morel F., Lardy B. Heme oxygenase-1 regulates matrix metalloproteinase MMP-1 secretion and chondrocyte cell death via Nox4 NADPH oxidase activity in chondrocytes. PLoS One 2013, 8.
298. Haines D.D., Lekli I., Teissier P., Bak I., Tosaki A. Role of haeme oxygenase-1 in resolution of oxidative stress-related pathologies: focus on cardiovascular, lung, neurological and kidney disorders. Acta Physiol (Oxf.) 2012, 204:487-501.
299. Guillen M.I., Megias J., Clerigues V., Gomar F., Alcaraz M.J. The CO-releasing molecule CORM-2 is a novel regulator of the inflammatory process in osteoarthritic chondrocytes. Rheumatology (Oxford) 2008, 47:1323-1328.
300. Hougee S., Hartog A., Sanders A., Graus Y.M., Hoijer M.A., Garssen J., van den Berg W.B., van Beuningen H.M., Smit H.F. Oral administration of the NADPH-oxidase inhibitor apocynin partially restores diminished cartilage proteoglycan synthesis and reduces inflammation in mice. Eur. J. Pharmacol. 2006, 531:264-269.
301. Pelletier J.P., Jovanovic D.V., Lascau-Coman V., Fernandes J.C., Manning P.T., Connor J.R., Currie M.G., Martel-Pelletier J. Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level. Arthritis Rheum. 2000, 43:1290-1299.
302. Bedford M.T., Clarke S.G. Protein arginine methylation in mammals: who, what, and why. Mol. Cell 2009, 33:1-13.
303. Alderton W.K., Cooper C.E., Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 2001, 357:593-615.
304. Fermor B., Weinberg J.B., Pisetsky D.S., Guilak F. The influence of oxygen tension on the induction of nitric oxide and prostaglandin E2 by mechanical stress in articular cartilage. Osteoarthr. Cartil. 2005, 13:935-941.
305. More A.S., Kumari R.R., Gupta G., Lingaraju M.C., Balaganur V., Pathak N.N., Kumar D., Sharma A.K., Tandan S.K. Effect of iNOS inhibitor S-methylisothiourea in monosodium iodoacetate-induced osteoathritic pain: implication for osteoarthritis therapy. Pharmacol. Biochem. Behav. 2013, 103:764-772.
306. Hellio le Graverand M.P., Clemmer R.S., Redifer P., Brunell R.M., Hayes C.W., Brandt K.D., Abramson S.B., Manning P.T., Miller C.G., Vignon E. A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee. Ann. Rheum. Dis. 2013, 72:187-195.
307. McCartney-Francis N., Allen J.B., Mizel D.E., Albina J.E., Xie Q.W., Nathan C.F., Wahl S.M. Suppression of arthritis by an inhibitor of nitric oxide synthase. J. Exp. Med. 1993, 178:749-754.
308. Hansel T.T., Kharitonov S.A., Donnelly L.E., Erin E.M., Currie M.G., Moore W.M., Manning P.T., Recker D.P., Barnes P.J. A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics. FASEB J. 2003, 17:1298-1300.
309. Amin A.R., Attur M.G., Thakker G.D., Patel P.D., Vyas P.R., Patel R.N., Patel I.R., Abramson S.B. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:14014-14019.
310. Lu H., Zeng C., Zhao H., Lian L., Dai Y. Glatiramer acetate inhibits degradation of collagen II by suppressing the activity of interferon regulatory factor-1. Biochem. Biophys. Res. Commun. 2014, 448:323-328.
311. Moon S.J., Woo Y.J., Jeong J.H., Park M.K., Oh H.J., Park J.S., Kim E.K., Cho M.L., Park S.H., Kim H.Y., Min J.K. Rebamipide attenuates pain severity and cartilage degeneration in a rat model of osteoarthritis by downregulating oxidative damage and catabolic activity in chondrocytes. Osteoarthr. Cartil. 2012, 20:1426-1438.
312. Cheleschi S., Cantarini L., Pascarelli N.A., Collodel G., Lucherini O.M., Galeazzi M., Fioravanti A. Possible chondroprotective effect of canakinumab: an in vitro study on human osteoarthritic chondrocytes. Cytokine 2015, 71:165-172.
313. Vuolteenaho K., Kujala P., Moilanen T., Moilanen E. Aurothiomalate and hydroxychloroquine inhibit nitric oxide production in chondrocytes and in human osteoarthritic cartilage. Scand. J. Rheumatol. 2005, 34:475-479.
314. de Isla N.G., Mainard D., Muller S., Stoltz J.F. In vitro effects of diacerein on NO production by chondrocytes in response to proinflammatory mediators. Biomed. Mater. Eng. 2008, 18:S99-104.
315. de Isla N.G., Stoltz J.F. In vitro inhibition of IL-1beta catabolic effects on cartilage: a mechanism involved on diacerein anti-OA properties. Biorheology 2008, 45:433-438.
316. Pelletier J.P., Mineau F., Boileau C., Martel-Pelletier J. Diacerein reduces the level of cartilage chondrocyte DNA fragmentation and death in experimental dog osteoarthritic cartilage at the same time that it inhibits caspase-3 and inducible nitric oxide synthase. Clin. Exp. Rheumatol. 2003, 21:171-177.
317. Fioravanti A., Tinti L., Pascarelli N.A., Di Capua A., Lamboglia A., Cappelli A., Biava M., Giordani A., Niccolini S., Galeazzi M., Anzini M. In vitro effects of VA441, a new selective cyclooxygenase-2 inhibitor, on human osteoarthritic chondrocytes exposed to IL-1beta. J. Pharmacol. Sci. 2012, 120:6-14.
318. Ding Q.H., Ji X.W., Cheng Y., Yu Y.Q., Qi Y.Y., Wang X.H. Inhibition of matrix metalloproteinases and inducible nitric oxide synthase by andrographolide in human osteoarthritic chondrocytes. Mod. Rheumatol. 2013, 23:1124-1132.
319. Valvason C., Musacchio E., Pozzuoli A., Ramonda R., Aldegheri R., Punzi L. Influence of glucosamine sulphate on oxidative stress in human osteoarthritic chondrocytes: effects on HO-1, p22(Phox) and iNOS expression. Rheumatology (Oxford) 2008, 47:31-35.
320. Chan P.S., Caron J.P., Orth M.W. Effect of glucosamine and chondroitin sulfate on regulation of gene expression of proteolytic enzymes and their inhibitors in interleukin-1-challenged bovine articular cartilage explants. Am. J. Vet. Res. 2005, 66:1870-1876.
321. Shikhman A.R., Kuhn K., Alaaeddine N., Lotz M. N-acetylglucosamine prevents IL-1 beta-mediated activation of human chondrocytes. J. Immunol. 2001, 166:5155-5160.
322. Kim H.A., Yeo Y., Jung H.A., Jung Y.O., Park S.J., Kim S.J. Phase 2 enzyme inducer sulphoraphane blocks prostaglandin and nitric oxide synthesis in human articular chondrocytes and inhibits cartilage matrix degradation. Rheumatology (Oxford) 2012, 51:1006-1016.
323. Rufino A.T., Ribeiro M., Sousa C., Judas F., Salgueiro L., Cavaleiro C., Mendes A.F. Evaluation of the anti-inflammatory, anti-catabolic and pro-anabolic effects of E-caryophyllene, myrcene and limonene in a cell model of osteoarthritis. Eur. J. Pharmacol. 2015, 750:141-150.
324. Chabane N., Zayed N., Afif H., Mfuna-Endam L., Benderdour M., Boileau C., Martel-Pelletier J., Pelletier J.P., Duval N., Fahmi H. Histone deacetylase inhibitors suppress interleukin-1beta-induced nitric oxide and prostaglandin E2 production in human chondrocytes. Osteoarthr. Cartil. 2008, 16:1267-1274.
325. Cao K., Wei L., Zhang Z., Guo L., Zhang C., Li Y., Sun C., Sun X., Wang S., Li P., Wei X. Decreased histone deacetylase 4 is associated with human osteoarthritis cartilage degeneration by releasing histone deacetylase 4 inhibition of runt-related transcription factor-2 and increasing osteoarthritis-related genes: a novel mechanism of human osteoarthritis cartilage degeneration. Arthritis Res. Ther. 2014, 16:491.
326. Zhang X., Zhu Y., Chen X., Zhang Y., Jia Y., Wang H., Liu Y., Xiao L. Baicalein ameliorates inflammatory-related apoptotic and catabolic phenotypes in human chondrocytes. Int. Immunopharmacol. 2014, 21:301-308.
327. Burguera E.F., Vela-Anero A., Magalhaes J., Meijide-Failde R., Blanco F.J. Effect of hydrogen sulfide sources on inflammation and catabolic markers on interleukin 1beta-stimulated human articular chondrocytes. Osteoarthr. Cartil. 2014, 22:1026-1035.
328. Hu P., Chen W., Bao J., Jiang L., Wu L. Cordycepin modulates inflammatory and catabolic gene expression in interleukin-1beta-induced human chondrocytes from advanced-stage osteoarthritis: an in vitro study. Int. J. Clin. Exp. Pathol. 2014, 7:6575-6584.
329. Ying X., Peng L., Chen H., Shen Y., Yu K., Cheng S. Cordycepin prevented IL-beta-induced expression of inflammatory mediators in human osteoarthritis chondrocytes. Int. Orthop. 2014, 38:1519-1526.
330. Ho L.J., Hung L.F., Liu F.C., Hou T.Y., Lin L.C., Huang C.Y., Lai J.H. Ginkgo biloba extract individually inhibits JNK activation and induces c-Jun degradation in human chondrocytes: potential therapeutics for osteoarthritis. PLoS One 2013, 8.
331. Xu Y., Dai G.J., Liu Q., Liu Z.L., Song Z.Q., Li L., Chen W.H., Lin N. Sanmiao formula inhibits chondrocyte apoptosis and cartilage matrix degradation in a rat model of osteoarthritis. Exp. Ther. Med. 2014, 8:1065-1074.